Phillips-Medisize Corporation announced today the appointment of Richard Even as General Manager of BioPharma and the medical campus in Menomonie, Wisconsin. This is the latest in a series of strategic hires driven by the company’s continued growth in biopharma drug delivery devices, consumable diagnostics, and medical devices.
Mr. Even comes to Phillips-Medisize most recently from Nypro Healthcare, a division of Jabil. Over the period of 32 years, Even acquired a vast background focused on operational excellence across multiple medical and biopharma device markets, facilities and geographies. For the past six years, he has led operations in Asia, overseeing thousands of teammates across five facilities with a focus on markets including drug delivery, diagnostics and medical surgical devices. Prior to his experience in Asia, Even served in a number of pharmaceutical device plants that contract manufactured a range of products. He also has a long track record of continuous improvement through the deployment and implementation of Lean Principles in medical device and contract manufacturing environments.
With a multi-year history of over $100M in new business awards, supported by a sales pipeline exceeding $1B
in opportunity, Phillips-Medisize continues to invest in people and facilities to support biopharma, diagnostics,
and medical device customer-driven growth. Over the last twelve months alone, the company has added nearly
100 years of healthcare design, development, and contract manufacturing experience to its ranks.
Phillips-Medisize Corporation
phillipsmedisize.com
